Diagnostic aids for detection of oral precancerous conditions

International Journal of Oral Science

Volumn 5, Issue 2, 2013, Pages 59-65

  Messadi, Diana V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

early diagnosis; non invasive detection tools; oral precancerous lesions

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT;

CELL TRANSFORMATION; CLASSIFICATION; EARLY DIAGNOSIS; EQUIPMENT; FLUORESCENCE; HUMAN; LEUKOPLAKIA; LUMINESCENCE; METHODOLOGY; MOUTH TUMOR; PRECANCER; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; COLORING AGENTS; EARLY DETECTION OF CANCER; FLUORESCENCE; HUMANS; LEUKOPLAKIA, ORAL; LUMINESCENCE; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 84881572238     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2013.24     Document Type: Review

References (80)

1. Johnson NW, Warnakulasuriya S, Gupta PC et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011; 23(2): 237-246.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62(1): 10-29.
3. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 7(1): 1-10.
4. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45(4/5): 317-323.
5. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review. Oral Oncol 2001; 37(5): 401-418.
6. Lingen MW, Pinto A, Mendes RA et al. Genetics/epigenetics of oral premalignancy: current status and future research. Oral Diseases 2011; 17(Suppl 1): 7-22.
7. Albo D, Granick MS, Jhala N et al. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 1994; 32(6): 588-594.
8. Guillaud M, Zhang L, Poh C et al. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res 2008; 68(9): 3099-3107.
9. Ho PS, Chen PL, Warnakulasuriya S et al. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer 2009; 9: 260-267.
10. Barnes L, Eveson JW, Reichart P et al. World health organization. Classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005: 283-328.
11. Arduino PG, Surace A, Carbone M et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med 2009; 38(6): 540-544.
12. Mehanna HM, Rattay T, Smith J et al. Treatment and follow-up of oral dysplasia-a systematic review and meta-analysis. Head Neck 2009; 31(12): 1600-1609.
13. Leemans CR, Boudewijn JM, Braakhuis JM et al. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11(1): 9-22.
14. Bremmer JF, Braakhuis BJ, Brink J et al. A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest 2005; 85(12): 1481-1488.
15. Bremmer JF, Graveland AP, Braakhuis BJ et al. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev Res 2009; 2(1): 128-133.
16. Shpitzer T, Hamzany Y, Bahar G et al. Salivary analysis of oral cancer biomarkers. Br J Cancer 2009; 101(7): 1194-1198.
17. Liu J, Duan Y. Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol 2012; 48(7): 569-577.
18. Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol 2011; 3: 33-40.
19. Lange CJ. Exploring biomarkers in head and neck cancer. Cancer 2012; 118(16): 3882-3892.
20. Carnelio S, Rodrigues SJ, Shenoy R et al. A brief review of common oral premalignant lesions with emphasis on their management and cancer prevention. Indian J Surg 2011; 73(4): 256-261.
21. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53(3): 563-568.
22. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J Am Dent Assoc 2001; 132(Suppl 1): 7S-11S.
23. Cabay JR, Morton AH Jr, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med 2007; 36(5): 255-261.
24. Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J 2011; 56(3): 253-256.
25. Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent 2012; 2012: 540561.
26. Grinde B, Olsen I. The role of viruses in oral disease. J Oral Microbiol 2010; 2: 2127-2135.
27. D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011; 53(Suppl 1): S5-S11.
28. Ostwald C, Rutsatz K, Schweder JW et al. Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol 2003; 192(3): 145-148.
29. Hennessey PT, Westra HW, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 2009; 88(4): 300-306.
30. Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008; 13: 1003-1017.
31. Nasman A, Attner P, Hammarstedt L et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125(2): 362-366.
32. Schlecht HP. Oral human papillomavirus infection hazard of intimacy. J Am Med Assoc 2012; 307(7): 724-725.
33. Ho PS, Yang YH, Shieh TY et al. Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104(5): 647-652.
34. Shahid RA. Coming to America: betel nut and oral submucous fibrosis. J Am Dent Assoc 2010; 141(4): 423-428.
35. Bhattacharyya I, Chehal HK. White lesions. Otolaryngol Clin N Am 2011; 44(1): 109-131.
36. Sugerman PB, Savage NW, Walsh LJ et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13(4): 350-365.
37. Sugerman PB, Savage NW, Zhou X et al. Oral lichen planus. Clin Dermatol 2000; 18(5): 533-539.
38. Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012; 366(8): 723-732.
39. van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cirt Bucal 2009; 14(7): E310-E314.
40. Ho MW, Risk JM, Woolger JA et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol 2012; 48(10): 969-976.
41. Messadi DV, Wilder-Smith P, Wolinsky L. Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc 2009; 37(11): 789-798.
42. Steele TO, Meyers A. Early detection of premalignant lesions and oral cancer. Otolaryngol Clin N Am 2011; 44(7): 221-229.
43. Nair D, Pruthy R, Pawar U et al. Oral cancer: premalignant conditions and screening-an update. J Can Res Therap 2012; 8(Suppl 1): s57-s66.
44. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009; 1: 5-10.
45. Epstein JB, Silverman S Jr, Epstein JD et al. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 2008; 44(6): 538-544.
46. Lingen MW, Kalmar JR, Karrison T et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44(1): 10-22.
47. Rosin MP, Poh CF, Guillard M et al. Visualization and other emerging technologies as change makers for oral cancer prevention. Ann NY Acad Sci 2007; 1098: 167-183.
48. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: asystematic review of the literature. J Am Dent Assoc 2008; 139(7): 896-905.
49. Su WW, Yen AM, Chiu SY et al. A community-based RCT for oral cancer screening with toluidine blue. J Dent Res 2010; 89(9): 933-937.
50. Awan KH, Yang YH, Morgan PR et al. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity-a clinical and histological assessment. Oral Dis 2012; 18(8): 728-733.
51. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc 1999; 130(10): 1445-1457.
52. Rick GM. Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96(3): 252-258.
53. Svirsky JA, Burns JC, Carpenter WM et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 2002; 50(6): 500-503.
54. Scheifele C, Schimdt-Westhausen A, Detrich T et al. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 2004; 40(8): 824-828.
55. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 2004; 35(5): 378-384.
56. Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 2006; 17(3): 59-63.
57. TM (ViziLiteH) in visualizing oral mucosal lesions. Spec Care Dent 2006; 26(4): 171-174.
58. McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol 2009; 45(12): 227-231.
59. Lam S, MacAulay C, Palcic B. Detection and localization of early lung cancer by imaging techniques. Chest 1993; 103(1 Suppl): 12S-14S.
60. Park SY, Follen M, Milbourne A et al. Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt 2008; 13(1): 014029.
61. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14(4): 275-292.
62. Ebihara A, Liaw LH, Krasieva TB. Detection and diagnosis of oral cancer by light-induced fluorescence. Lasers Surg Med 2003; 32(1): 17-24.
63. Schantz SP, Kolli V, Savage HE et al. In vivo native cellular fluorescence and histological characteristics of head and neck cancer. Clin Cancer Res 1998; 4(5): 1177-1182.
64. Sweeny L, Dean NR, Magnuson JS et al. Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Otolaryngol Head Neck Surg 2012; 145(6): 956-960.
65. Lane PM, Gilhuly T, Whitehead P et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006; 11(2): 024006.
66. Poh CF, Ng SP, Williams PM et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007; 29(1): 71-76.
67. Balevi B. Evidence-based decision making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? J Can Dent Assoc 2007; 73(7): 603-606.
68. Camiles F, Mcintosh L, Georgiou A et al. Efficacy of tissue autofluorescence imaging (Velscope) in the visualization of oral mucosal lesions. Head Neck 2012; 34(6): 856-862.
69. TM) in the detection of oral potentially malignant disorders and benign keratosis. Oral Oncol 2011; 47(4): 274-277.
70. Roblyer D, Kurachi C, Stepanek V et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res 2009; 2(5): 423-431.
71. Folkman J, Watson K, Ingber D et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339(6219): 58-61.
72. Hasina R, Lingen MW. Angiogenesis in oral cancer. J Dent Educ 2001; 65(11): 1282-1290.
73. Schwarz RA, Gao W, Redden Weber C et al. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy: simple device for the direct visualization of oral-cavity tissue fluorescence. Cancer 2009; 115(8): 1669-1679.
74. McGee SA, Mirkovic J, Mardirossian V et al. Model-based spectroscopic analysis of the oral cavity: impact of anatomy. J Biomed Opt 2008; 13(6): 064034.
75. Koch FP, Kaemmerer PW, Biesterfeld S et al. Effectiveness of autofluorescence to identify suspicious oral lesions-a prospective, blinded clinical trial. Clin Oral Investig 2011; 15(6): 975-982.
76. Forde MD, Koka S, Eckert SE et al. Systemic assessments utilizing saliva: part 1 general considerations and current assessments. Int J Prosthodont 2006; 19(1): 43-52.
77. Pesce MA, Spitalnik SL. Saliva and the clinical pathology laboratory. Ann NY Acad Sci 2007; 1098: 192-199.
78. Li Y, St John MA, Zhou X et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004; 10(24): 8442-8450.
79. Wong DT. Towards a simple, saliva-based test for the detection of oral cancer, oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance. Expert Rev Mol Diagn 2006; 6(3): 267-272.
80. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006; 137(3): 313-321.